DANIEL KLEIN: Open Payments
NPI 1003480005 · VACAVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 28 payments from 14 companies in 2025. Trend: 2023 $263 · 2024 $506 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $401 |
| ABBVIE INC. | 5 | $114 |
| Intra-Sana Laboratories | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| ViiV Healthcare Company | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $29 |
| Medtronic, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| ALK-Abello, Inc | 1 | $23 |
Products named: Ozempic, Wegovy, QULIPTA, MOUNJARO, APRETUDE, MAVYRET, MINIMED 780G, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
